Introduction

Name

• Glucosamine.

Class of drug

• Nutraceutical.
• Amino acid.
• Chondroprotective agent.

Description

Chemical name

• Glucosamine.

Storage requirements

• Store in a dry place <25°C.
• Keep container tightly closed.

Uses

Indications

• A nutritional aid in the management of degenerative joint disease.
• Mild anti-inflammatory effect.

Administration

Adverse Reactions

Further Reading

Publications

Refereed papers

• Recent references from PubMed and VetMedResource.
• Lennox C E, Lunn K F (2010) Effects of glucosamine-chondroitin sulfate supplementation on serum-fructosamine concentration in healthy dogs. JAVMA 236 (2), 183-186 PubMed.
• Sauvé F, Paradis M, Refsal K R et al (2003) Effects of oral administration of meloxicam, carprofen, and a nutraceutical on thyroid function in dogs with osteoarthritis. Can Vet J 44 (6), 474-479 PubMed.
• Adebowale A, Du J, Liang Z et al (2002) The bioavailability and pharmacokinetics of glucosamine hydrochloride and low molecular weight chondroitin sulfate after single and multiple doses to beagle dogs. Biopharm Drug Dispos 23 (6), 217-225 PubMed.
• Anderson M A (1999) Oral chondroprotective agents. Part II. Evaluation of products. Comp Contin Ed Pract Vet 21 (9), 861-865 VetMedResource.
• Canapp S O Jr., McLaughlin R M Jr., Hoskinson J J et al (1999) Scintigraphic evaluation of dogs with acute synovitis after treatment with glucosaminehydrochloride and chondroitin sulfate.​ Am J Vet Res 60 (12), 1552-1557 PubMed.
• McIlwraith C W (1999) "Should I recommend the use of oral glycosaminoglycans?" Comp Contin Educ Pract Vet 21 (5), 450-451, 457 VetMedResource.
• Boothe D M (1998) Nutraceuticals in veterinary medicine. Part II. Safety and efficacy. Comp  Contin Educ Pract Vet 20 (1), 15-21 VetMedResource.
• Hulse D A (1998) Treatment methods for pain in the osteoarthritic patient. Vet Clin North Am Small Anim Pract 28 (2), 361-375 PubMed.
• Boothe D M (1997) Nutraceuticals in veterinary medicine. Part I. Definitions and regulations. Comp Contin Educ Pract Vet 19 (11), 1248-1255 VetMedResource.
• McNamara P S, Barr S C & Erb H N (1996) Hematologic, hemostatic and biochemical effects in dogs receiving an oral chondroprotective agent for thirty days. Am J Vet Res 57 (9), 1390-1394 PubMed.